Ignite Creation Date:
2025-12-25 @ 2:48 AM
Ignite Modification Date:
2026-05-30 @ 10:40 PM
Study NCT ID:
NCT06145633
Status:
RECRUITING
Last Update Posted:
2025-09-22
First Post:
2023-11-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RG1123920
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None